| Product Unit Size | Cost | Quantity | Stock |
|---|
Cholecalciferol (vitamin D3) is an endogenous prodrug of calcifediol; cholecalciferol is synthesized in the skin under UV-B exposure. Cholecalciferol supplements are occasionally used to prevent bone loss. D vitamins commonly exhibit anti-osteoporotic, immunomodulatory, anti-inflammatory, and chemopreventive activities.
| Cas No. | 67-97-0 |
|---|---|
| Purity | ≥98% |
| Formula | C27H44O |
| Formula Wt. | 384.64 |
| Chemical Name | (3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol |
| IUPAC Name | (1S,3Z)-3-[(2E)-2-[(1R,3aS, 7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6, 7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol |
| Synonym | oleovitamin D3, Vitamin D3 |
| Melting Point | 82-87°C |
| Solubility | Insoluble in water. Soluble in most organic solvents. |
| Appearance | White Crystalline Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Bendik I, Friedel A, Roos FF, et al. Vitamin D: a critical and essential micronutrient for human health. Front Physiol. 2014 Jul 11;5:248. PMID: 25071593.
Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013 Sep 30;5(10):3993-4021. PMID: 24084056.
Geddes JA, Inderjeeth CA. Evidence for the treatment of osteoporosis with vitamin D in residential care and in the community dwelling elderly. Biomed Res Int. 2013;2013:463589. PMID: 24058907.